Lv12
40 积分 2025-02-08 加入
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update
1小时前
待确认
Double Peaking Phenomena in Pharmacokinetic Disposition Revisited
23小时前
已完结
Sex- and gender-related differences in psoriatic arthritis
2个月前
已完结
Impact of Sex on Clinical Response in Rheumatoid Arthritis Patients Treated With Biologics at Approved Dosing Regimens
6个月前
已完结
A Phase I Clinical Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of GB221 Injection and Trastuzumab (Herceptin®) in Healthy Chinese Adults
6个月前
已完结
Lymphodepletion strategies to potentiate adoptive T-cell immunotherapy – what are we doing; where are we going?
7个月前
已完结
Sex differences in tissue-specific immunity and immunology
7个月前
已完结
Evaluation of proximod, a selective agonist of sphingosine-1-phosphate receptor-1, in healthy volunteers and patients with rheumatoid arthritis: a phase 1, double-blind, randomised, placebo-controlled, ascending dose trial
8个月前
已完结
皖公网安备34019202002308
